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Pancreatic damage induced by cigarette smoke:
the specific pathological effects of cigarette
smoke in the rat model
Senay Topsakal,a Ozlem Ozmen,*b Rahime Aslankocc and Demet Hancer Aydemird
In recent years, pancreatic pathologies have become common problems and their etiology and patho-
genesis are generally unknown. Studies have shown that smoking may increase the risk of pancreatic dis-
orders but very scant knowledge is available about the pathogenesis of cigarette induced pancreatic
pathology. This study aimed to evaluate the oxidative stress status, biochemical, pathological and
immunohistochemical findings of rats exposed to cigarette smoke, pathogenesis of smoking related pan-
creatic damage and usability of Alpha Lipoic Acid (ALA) for amelioration of cigarette smoking induced
harmful effects on rat pancreas. Twenty eight female, Sprague Dawley rats were randomly distributed into
three groups. The sham group (S) (n = 8), rats were given 0.1 ml of physiological serum by oral gavage for
8 weeks. The cigarette smoke exposed group (CSE) (n = 10), rats were exposed to successive periods of
cigarette smoke for 2 hours per day per 8 weeks and given 0.1 ml of physiological serum orally during the
study. The cigarette smoke exposed and ALA treated group (CSE + ALA) (n = 10), animals were exposed to
cigarette smoke (2 hours per day per 8 weeks) and simultaneously treated with 100 mg per kg per day
ALA orally during the study. At the end of the study, the serum samples were collected for insulin, gluca-
gon, glucose and amylase analyses. Tissue samples were collected for biochemical, histopathological and
immunohistochemical examinations. Total oxidant status (TOS), total antioxidant status (TAS) levels and
oxidative stress index (OSI) were evaluated in the pancreas samples. Immunohistochemical analyses of
insulin, glucagon, calcitonin gene related protein (CGRP), active caspase-3, hypoxia inducible factor-1
(Hif-1), Hif-2 and tumor necrosis factor (TNF-α) expressions of pancreas were examined. Cigarette smoke
caused statistically significant increase in serum amylase and glucose but decreased insulin levels indicat-
ing both endocrine and exocrine cell damage. There were no statistically significant differences in serum
glucagon levels between the groups. Histopathological examination of the pancreas exhibited generally
normal tissue architecture but slightly degenerative and apoptotic cells were noticed both in the endo-
crine and exocrine part of the pancreas in the CSE group. Immunohistochemical analyses revealed
marked increase in active caspase-3, Hif-1 and Hif-2, CGRP and TNF-α expressions with a slight increase
in glucagon immunoreactivity in cells while a marked decrease was observed in insulin expression in
some Langerhans islets in the CSE group. ALA ameliorated biochemical and pathological findings in the
CSE + ALA group. These findings clearly demonstrated that cigarette smoke can cause damage in both
endocrine and exocrine cells in rat pancreas and ALA has an ameliorative effect of cigarette induced
lesions.
Introduction
In the modern world smoking is one of the major environ-
mental health risk factors affecting almost all the organs or
systems of human body.1 Smoking has become a common
serious health and societal problem in the last century. It
can cause numerous problems in organs and their function,
and cause different diseases including respiratory, cardio-
vascular, cerebral, and peripheral vascular diseases and
especially cancer.2,3 In relation to pancreatic pathology,
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smoking has been described as an important risk factor
for endocrine and exocrine pancreatic functions and the
most common environmental risk factor for pancreatic
cancer.1,4
Recent human studies have reported that the possible
increase of the risk of pancreatitis in a dose-dependent
manner is due to smoking but in contrast some studies
have reported no correlation with pancreatic lesions and
smoking.5–8 It has been reported that smoking increases by
approximately 2-fold the risk of non-gallstone related acute
pancreatitis, but not for gallstone-related pancreatitis.7
Andriulli et al. reported that smoking increases 25% of the
risk for chronic pancreatitis.6 But there is very little infor-
mation about the pathogenesis of smoking-induced pancreatic
pathology. Data from animal models suggest several potential
mechanisms such as altered gene expression in the exocrine
pancreas and activation of pancreatic enzymes with acinar cell
damage. Nicotine modulated the oxidative stress and lipid per-
oxidation and these processes might be involved in the patho-
physiology of acute and chronic pancreatitis.9
Diabetes mellitus is a group of metabolic diseases charac-
terized by hyperglycemia resulting from defects in insulin
secretion or action.10 It is a life-long disease and swiftly
increasing in all age groups and both genders. It causes pro-
blems in various physiological functions of organs or multiple
systems,11 and is associated with wide ranging and devastating
health complications.12 Although some authors report many
relative effects of smoking and diabetes, little and contradic-
tory knowledge is available about the effect of smoking
on pancreatic endocrine cells and functions.13–15 The patho-
genesis of the damage of smoking on pancreas is, however, not
yet well understood, and it remains to be elucidated. Because of
these reasons, new experimental studies are needed to explain
the effect of cigarette smoke on pancreas. The aim of this
study was to examine the pancreatic pathology by histopatho-
logical, immunohistochemical and biochemical methods in rats
exposed to cigarette smoke for 8 weeks and effects of ALA
against cellular damage.
Materials and methods
All experiments were performed in accordance with the guide-
lines for animal research from the National Institutes of
Health and were approved by the Committee on Animal
Research of Suleyman Demirel University, Isparta. Twenty
eight female, Sprague Dawley skeletal development completed
six-month old rats weighing 250–300 g were placed in a temp-
erature (21–22 °C) and humidity (60 ± 5%) controlled room in
which a 12 : 12 h light : dark cycle was maintained. All the rats
were fed with standard commercial chow diet (Korkuteli Yem
A.S.). Thioctacid 600 mg tablets (MEDA Pharma, Turkey)
which are a commercial form of Alpha Lipoic Acid (ALA) were
used for treatment. A single dose per day of 100 mg kg−1 for
oral administration was prepared in a saline solution for the
experiment.16
Cigarette smoke exposures were performed using commer-
cially available filter cigarettes (Turkey Tobacco Industrial. Co.,
Ltd, Tekel 2000, Turkey). According to the product specifica-
tions, each cigarette contained 1 mg of nicotine, 10 mg of tar
and 10 mg carbon monoxide. The smoking apparatus consists
of three major parts, including a glass chamber with a glass
door (large cube), a cigarette burner system with an inhalation
apparatus (small cube), and a ventilation apparatus (one-way
valve) on the top of the chamber.17,18 A 75 cm (length) × 75 cm
(width) × 50 cm (height) glass chamber was separated into two
layers with sufficient space for exposing 20 rats at a time
(Fig. 1). The cigarette burner system (A 25 cm (length) × 15 cm
(width) × 15 cm (height)) contains one cigarette holder and a
300 ml glass syringe which could burn up 1 cigarette in
10 minutes and inject cigarette smoke into the chamber (large
cube) by manual control of one-way valves. After cigarette
smoke exposure the ventilation apparatus would pump out all
of the smoke in the chamber within 5 min after exposure.
During the experiment, the temperature was maintained in the
range of 21–23 °C in the apparatus and the carbon monoxide
ratio was maintained in the range of 310–380 ppm.19 Animals
were inserted into the apparatus and exposed to cigarette
smoke in successive periods of 1 hour in the morning and
1 hour in the afternoon throughout 7 days a week for 8 weeks.
According to ten minutes for burning time and five minutes
for aeration of one cigarette smoke for controlling CO levels,
the session completed in a total of 90 minutes for 6 cigarette
smoke exposure. Increasing amount of smoke exposure is
planned as follows: first day 3 cigarettes; second day 7 cigarettes;
third day 5 up to 12 cigarettes per day (30 min) and 6th to 8th day
12 cigarettes until the end of the week (1 hour period at 2 times).
The rats were randomly divided into three groups:
(1) Sham (S) group (n = 8); animals were placed into the
same type of apparatus as described in the cigarette smoke
exposed group, but were exposed to fresh air instead of
Fig. 1 The experimental setup of the CSE exposure system.
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cigarette smoke and given 0.1 ml of physiological serum by
gavage for 8 weeks.
(2) Cigarette smoke exposure (CSE) group (n = 10); animals
were placed in the chamber and exposed to successive periods
of cigarette smoke for 1 h in the morning and 1 h in the after-
noon, 7 days for 8 weeks and given 0.1 ml of physiological
serum orally for 8 weeks simultaneously.
(3) CSE + ALA group (n = 10); animals were placed in the
chamber and exposed to successive periods of cigarette smoke
for 1 h in the morning and 1 h in the afternoon, 7 days
for 8 weeks and given 100 mg kg−1 d−1 orally for 8 weeks;
simultaneously.
At the end of the experiment, rats were euthanized by keta-
mine (80 mg kg−1)/xylazine anaesthesia (10 mg kg−1) applied
24 hours after the last ALA administration. After the abdomi-
nal incision; blood samples were collected from vena cava
inferior and extracted to determine the serum insulin, gluca-
gon, glucose and amylase levels. An autoanalyser (Beckman
Coulter AU680, Brea, California, USA) was used for analyzing
the serum glucose and amylase levels. Serum insulin and gluca-
gon levels were analyzed by a commercial ELISA kit pur-
chased from Merck Millipore (Masseuses, USA) using an
ultrasensitive rat/mouse insulin ELISA kit (EZRNI-13K) and a
glucagon ELISA Kit, chemiluminescent (EZGLU-30K) respect-
ively with a multiplate ELISA reader (EPOCH microplate
reader; Bio-Tek, Inc., Vermont, USA).
Pancreases were quickly removed and divided equally into
two longitudinal sections. One half of tissues were placed in a
10% neutral formaldehyde solution for routine histopathologi-
cal and immunohistochemical examinations (caspase-3, CGRP,
Hif-1, Hif-2, TNF-α, insulin and glucagon). The other half of the
tissues were homogenized and kept at −80 °C for biochemical
studies [total oxidant status (TOS), total antioxidant status (TAS)
levels and oxidative stress index (OSI)]. For biochemical ana-
lyses, pancreatic tissue samples were collected and homo-
genized in a motor-driven tissue homogenizer (IKA Ultra-Turrax
T25 Basic; Labortechnic, Staufen, Germany) and sonicator
(UW-2070 Bandelin Electronic, Germany) with phosphate buffer
(pH 7.4). Unbroken cells, cell debris, and nuclei were sedimen-
ted by centrifugation at 10 000g for 10 min. The levels of protein
were determined in the supernatants. Protein levels in the homo-
genate were determined according to the method of Bradford
et al.19 Determination of TOS and TAS; Rel Assay, a novel auto-
mated colorimetric kit which was developed by Erel, was used
for determination of TOS and TAS of tissues samples.20,21 The
color intensity was related to the total amount of oxidant mole-
cules and the change of absorbance at 660 nm was related to
the total antioxidant level of the sample which can be
measured spectrophotometrically, as shown in the sample.
The results are expressed in terms of mM hydrogen peroxide
equivalent per g liter (mmol H2O2 equiv. l
−1, mmol H2O2
equiv. per mg protein) for TOS levels and mmol Trolox eq. per
mg protein for TAS levels. TAS and TOS were measured spectro-
photometrically by an automated chemistry analyzer Beckman
Coulter AU5800 (Tokyo, Japan). Determination of OSI which
stands for an indicator parameter of the oxidative stress level,
and the ratio of TOS to TAS were made using the following
formula.22 OSI (arbitrary unit) = TOS/TAS × 100.
For histopathological examination, pancreas samples were
collected during necropsy and fixed in 10% neutral formalin
solution. After two days, the fixed samples were routinely pro-
cessed and embedded in paraffin, and 5 µm sections were
obtained using a Leica RM 2155 rotary microtome. Then the
sections were stained with hematoxylin-eosin (HE) and exam-
ined under a light microscope. Histopathological changes were
graded in a blinded manner and lesions scored for evaluation
of the pathological findings by a specialized pathologist from
another university who was unaware of the study design. Scores
were made according to the numbers of the degenerative cells.
To evaluate the percentage of degenerated cells, 10 different
areas of both endocrine and exocrine parts were examined in
each rat pancreas under the 40× objective of an Olympus CX41
light microscope. Morphometric evaluation was made by using
the Database Manual Cell Sens Life Science Imaging Software
System (Olympus Corporation, Tokyo, Japan). Pancreas samples
were then immunostained with primary antibodies. All anti-
bodies were purchased from the Abcam, Cambridge, UK.
Selected tissue sections were immunostained by Calcitonin
Gene Related Protein [Anti CGRP antibody [4901] (ab81887)];
caspase-3 [anti-caspase-3 antibody (ab4051)]; insulin [anti-
insulin + proinsulin antibody, [D6D4] Abcam (ab8304)], gluca-
gon [anti-glucagon antibody, Abcam (ab8055)], Hif-1 [anti-
HIF-1-alpha (H1alpha67) antibody – ChIP Grade ab1], Hif-2
[anti-HIF-2-alpha [ep190b] antibody ab8365], and TNF [anti-TNF
alpha antibody (ab6671)] antibodies according to the manufac-
turer’s instructions. All the slides were analyzed for immuno-
positivity and a semiquantitative analysis was carried out. The
samples were analyzed by examining five different sections in
each sample, which were then scored from 0 to 3 according to
the intensity of staining (0, absence of staining; 1, slight, 2,
medium and 3, marked). Negative controls were incubated with
a blocking solution without primary antibodies.
Variables were presented as frequencies, percentages, mean
± standard deviations, median or min–max. The Kolmogorov–
Smirnov and Shapiro–Wilk tests were used to test for a normal
distribution of continuous variables, and the Levene test was
used for homogeneity of variance. Data characterized by a
normal distribution were expressed as mean ± standard devi-
ation. Parameters without such distribution were expressed as
median with range. The groups were compared using a non-
parametric Kruskal–Wallis test and a Mann–Whitney-U test.
Biochemical parameters were shown to fit with the normal dis-
tribution and ANOVA and post hoc LSD tests were used to
compare the groups. Calculations were made using the SPSS
15.0 program pack (SPSS Inc., Chicago, IL, USA). P < 0.05 was
set as the value for significance.
Results
In this study, statistically significant increase in serum glucose
and amylase levels were observed in the CSE group and ALA
Paper Toxicology Research
940 | Toxicol. Res., 2016, 5, 938–945 This journal is © The Royal Society of Chemistry 2016
D
ow
nloaded from
 https://academ
ic.oup.com
/toxres/article-abstract/5/3/938/5568603 by Pam
ukkale U
niversity user on 01 July 2020
treatment decreased the levels in the CSE + ALA group. Results
of serum samples are shown in Table 1. Serum insulin and
glucagon analysis revealed statistically significant decrease in
this hormone level but cigarette smoking did not significantly
affect the serum glucagon level (Table 2). This study results
indicated both endocrine and exocrine cell damage due to
cigarette smoke exposure in pancreas.
In the present study it was observed that cigarette smoke
caused a statistical increase in TOS and OSI levels (p < 0.05
and p < 0.05; respectively), while causing a decrease in TAS
levels (p < 0.001). In accordance with these parameters, TOS
levels were decreased (p < 0.05) and TAS levels were increased
(p < 0.05) in the ALA treated groups. Oxidative stress markers
of pancreatic tissue are shown in Table 3. These results also
supported cigarette smoke induced pancreatic cell damage.
Histopathological examination of the pancreases revealed
that they generally retained their normal tissue architecture
but slightly degenerative cells were noticed in both endocrine
and exocrine part of the pancreas in the CSE group. Most of
the cells exhibited vacuolar and some of the cells exhibited
hydropic degeneration (cell swelling). Very rarely cells with
pyknotic and karyorrhectic nuclei were also seen. A small
number of apoptotic cells were observed in pancreas of the
CSE group. Histopathological evaluation showed no pancreatic
inflammation in any group (Fig. 2). In the S group no patho-
logical lesions were observed. ALA treatment caused marked
amelioration in the CSE + ALA groups’ pancreatic cells.
Immunohistochemistry revealed a decrease in insulin
secreting cell numbers and severity of expression with a slight
increase in glucagon secreting cells. In addition immunohisto-
chemically marked increase in active caspase-3, Hif-1, Hif-2,
CGRP and TNF-α expressions in both exocrine and Langerhans
islets were noticed in the CSE group (Fig. 3–9). ALA treatment
ameliorated the biochemical and pathological findings in the
CSE + ALA group.
Discussion
In this study, the effects of cigarette smoke inhalation on pan-
creas were examined by biochemical and pathological
methods. The oxidative stress markers, histopathological cell
damage, active caspase-3, CGRP, TNF-α, Hif-1, Hif-2, insulin
and glucagon expressions in the groups were evaluated. A
marked increase was observed in active caspase-3, Hif-1, Hif-2
CGRP, TNF-α and relatively slight increase in glucagon
expressions while a marked decrease was observed in insulin
secretion in some Langerhans islets in the cigarette smoke
exposed group related to pancreatic damage. In addition gene
expressions except insulin and glucagon were also increased in
exocrine cells of the pancreas in the CSE group.
In the present study, exposure to cigarette smoke increased
serum glucose concentrations in rats. Immunohistochemical
examination of the Langerhans islet revealed marked decrease
in insulin expression in some islets. These biochemical and
immunohistochemical results were parallel to each other.
While the glucagon expression increased in the pancreas there
were no statistically significant differences in serum glucagon
Table 1 Serum glucose and amylase levels between the groups
Groups
Glucose (mg dl−1) Amylase (U l−1)
Mean ± SD Mean ± SD
S 238.16 ± 41.44 416.57 ± 37.29
CSE 280.60 ± 83.55 518.42 ± 64.33
CSE + ALA 206.42 ± 23.27 394.00 ± 52.99
P value S-CSE (0.05) S-CSE (0.05)
S-CSE + ALA (NS) S-CSE + ALA (NS)
CSE-CSE + ALA (0.05) CSE-CSE + ALA (0.001)
Values are presented as means ± SD. The relationships between groups
and results of biochemical markers are assessed by one-way ANOVA.
NS: not significant.
Table 2 Serum insulin and glucagon levels between the groups
Groups
Insulin (ng ml−1) Glucagon (pg ml−1)
Mean ± SD Mean ± SD
S 0.65 ± 0.03 81.20 ± 5.84
CSE 0.46 ± 0.04 85.20 ± 1.98
CSE + ALA 0.54 ± 0.02 77.10 ± 4.55
P value S-CSE (0.05) S-CSE (NS)
S-CSE + ALA (0.05) S-CSE + ALA (NS)
CSE-CSE + ALA (0.05) CSE-CSE + ALA (NS)
Values are presented as means ± SD. The results of insulin and
glucagon between the groups are assessed by one-way ANOVA. NS: not
significant.
Table 3 Oxidative stress markers status of pancreas
Groups
TAS (mmol Trolox equivalents per l) TOS (µmol H2O2 equiv. l
−1) OSİ
Mean ± SD Mean ± SD Mean ± SD
S 0.96 ± 0.44 11.99 ± 5.38 2.95 ± 1.50
CSE 0.19 ± 0.17 24.65 ± 9.95 6.05 ± 2.88
CSE + ALA 0.53 ± 0.21 12.83 ± 5.58 3.33 ± 0.83
P value S-CSE (0.05) S-CSE (0.05) S-CSE (0.05)
S-CSE + ALA (0.05) S-CSE + ALA (NS) S-CSE + ALA (NS)
CSE-CSE + ALA (0.05) CSE-CSE + ALA (0.05) CSE-CSE + ALA (0.05)
Values are presented as means ± SD. The relationships between groups and results of biochemical markers are assessed by one-way ANOVA. NS:
not significant
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levels. This result showed that increased immunohisto-
chemical expression of glucagon may be a relative occurrence
and insulin secreting cells may be more susceptible to ciga-
rette smoke than glucagon secreting cells. Increased glucagon
secreting cells and decreased insulin secreting cells show a
possible diabetogenic effect of smoking. These findings were
in agreement with previous studies showing alterations in
glucose metabolism and sensitivity to insulin in smokers.
Chronic cigarette users are generally hyperinsulinaemic and
relatively intolerant to glucose when compared with non-
smokers.23 Smoking has been established as a risk factor for
incident type 2 DM.24
Acute pancreatitis is characterized by sudden inflammation
of the pancreas due to injury from a variety of causes. Chronic
pancreatitis is an inflammatory disease characterized by long-
standing injury and irreversible structural and functional
impairment of the pancreas.25,26 The cellular mechanisms
through which smoking causes pancreatitis remain
Fig. 2 Histopathological appearance of the pancreas. (A) Normal tissue architecture in the S group. (B) Slight vacuolar degeneration in both endo-
crine and exocrine cells (arrows) in the CSE group, (C) normal histology in the CSE + ALA group; HE, bars = 50 µm.
Fig. 3 Insulin immunoreaction between the groups. Normal expressions in S (A) and CSE + ALA (C) groups. Decrease in severity and insulin secreted
cell numbers in Langerhans islet in the CSE group (B), streptavidin biotin peroxidase method, bars = 50 µm.
Fig. 4 Glucagon expressions between the groups. Normal expression in S (A) and CSE + ALA (C) groups. Increase in severity and glucagon secreted
cell numbers in Langerhans islet in the CSE group (B), streptavidin biotin peroxidase method, bars = 50 µm.
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unknown.27,28 Cigarette smoking affects tissues, either directly,
as is the case in the respiratory tract, or indirectly via the many
circulating toxins and metabolic products of tobacco smoke.29
Nicotine is a significant constituent of tobacco and cigarettes
and potentially mediates the development of pancreatic
disease. A number of experimental studies exploring the
effects of nicotine on the pancreas have been implemented.
Nicotine exposure resulted in morphological changes in the
exocrine pancreas including cytoplasmic swelling, vacuoliza-
tion, pyknotic nuclei, and karyorrhexis.27,28 The pathological
and biochemical changes observed in these studies reflect
similar cellular reactions. But the severity of the inflammatory
reaction was not prominent. A possible cause of slight finding
may be related to the duration of the study. To explain the
time related effect of smoking on pancreas, further studies are
needed.
Fig. 5 Caspase-3 expressions of the groups. (A) Negative caspase-3 immunoreaction in pancreas in the S group. (B) Marked increase in endocrine
and exocrine cells (arrows) in the CSE group. (C) Decreased caspase-3 expression in Langerhans islet cells (arrows) in the CSE + ALA group, streptavi-
din biotin peroxidase method, bars = 50 µm.
Fig. 6 Hif-1 expressions between the groups. Negative immunoreaction in S (A) and CSE + ALA (C) groups. Increased Hif-1 expression (arrows) in
the CSE group (B), streptavidin biotin peroxidase method, bars = 50 µm.
Fig. 7 Hif-2 expressions between the groups. Negative immunoreaction in S (A) and CSE + ALA (C) groups. Increased Hif-2 expression (arrows) in
both endocrine and exocrine cells of pancreas in the CSE group (B), streptavidin biotin peroxidase method, bars = 50 µm.
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Apoptosis is a controlled active physiological process that
removes unwanted or defective cells by intrinsically pro-
grammed cell suicide and characterized by some morphologi-
cal changes and caused by an enzyme family of proteases
named caspases. They are inactive proenzymes in cytosol that
are activated when apoptosis is initiated; they play an essential
role during various stages of apoptosis.30–32 In this study the
most marked expression were observed at active caspase-3
expression. This result showed us that one of the most impor-
tant mechanisms of cigarette induced cellular damage might
be related to apoptosis.
Hypoxia is one of the other major reasons of degeneration
in cells and they can respond to hypoxia with a series of events
that include regulation of gene expression.33 The transcription
factors activated during low oxygen conditions are called
hypoxia-inducible factors (HIFs) and they play important roles
in cell metabolism and damage.34 In this study smoke
increased both Hif-1 and Hif-2 expressions in pancreas in the
CSE group. Activation of the Hif-1 and -2 expression may be
one of the other mechanisms of pancreatic injury that is trig-
gered by cigarette smoke.
The TNF-α is a proinflammatory cytokine produced primar-
ily by mononuclear phagocytes and numerous cells after
stimulation by immune reactions.35 In this study, although
there were no marked inflammatory cell infiltration in pan-
creas, increase in TNF-α immunoreaction showed that ciga-
rette smoke can cause inflammation and proinflammatory
cytokine secretion in pancreatic cells.
The increased formation of reactive oxygen species (ROS) or
inefficiency of the antioxidant system,36,37 induces lipid peroxi-
dation in cell structures and causes cellular damage.37,38
Chronic tobacco cigarette consumption is a source of oxidative
stress.39 Our study findings were in agreement with a previous
study and we observed one of the main pathways of the pan-
creatic cell damage induced by cigarette smoke via oxidative
stress.
Some studies carried out have reported about ALA having a
protective effect against free radicals and plays a protective role
against oxidative stress in cells.39–41 Similarly ALA had a pro-
tective effect against pancreatic damage triggered by smoking
in this study.
We investigated the association of cigarette smoke and pan-
creatic pathology in rats. These study findings clearly demon-
strated that cigarette smoke can cause damage in both
endocrine and exocrine cells of the rat pancreas and ALA has
an ameliorative effect of cigarette induced findings. One of the
Fig. 8 CGRP immunoreaction between the groups. (A) Negative immunoreaction in the S group. (B) Marked increase in CGRP expression (arrows) in
endocrine cells of pancreas in the CSE group (arrows), (C) decrease expression of CGRP (arrows) in the CSE + ALA group. Streptavidin biotin peroxi-
dase method, bars = 50 µm.
Fig. 9 TNF-α expression between the groups. Negative immunoreaction in S (A) and CSE + ALA (C) groups. Increase TNF-α expression (arrows) in
Langerhans islet cells of pancreas in the CSE group (B), streptavidin biotin peroxidase method, bars = 50 µm.
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possible mechanisms of the cell damage observed was oxidative
stress that was characterized by high levels of oxidative stress
markers. The other mechanism was inducing apoptotic activity
that was related to increased caspase-3 immunoreaction in the
cells. One of the other mechanisms was increased inflammatory
process produced by cigarette smoke, TNF-α and CGRP which
had an important role in cigarette related pancreatic damage.
In summary, our results show that cigarette exposure leads to
an increase in apoptotic activity, TNF-α and CGRP expression,
glucagon immunoreaction and decrease in insulin expression
which are associated with pancreatic damage.
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